Docusate Sodium Capsule, Liquid Filled
Product Images NDC 45802-486

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 45802-486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Docusate Sodium Container Image 1 Of 2 (Container Image 1 Of 2)

Label for Docusate Sodium 100 mg softgel capsules, a stool softener laxative by Padagis Israel Pharmaceuticals Ltd. The label includes drug facts such as active ingredient, usage, warnings, directions, and inactive ingredients. It specifies 100 softgels in the package and highlights that the product is gentle, dependable, and stimulant-free.*

FDA Label Image

Docusate Sodium Container Image 2 Of 2 (Container Image 2 Of 2)

Drug Facts panel for Docusate Sodium oral liquid-filled capsules. Visible sections include warnings to keep out of reach of children and a poison control contact, directions indicating dosing by age groups (adults and children 12 years and older: 1-3 softgels daily; children 6 to under 12 years: 1 softgel daily; children under 2 years: ask a doctor).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.